KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
OncoTargets and Therapy Aug 26, 2017
Xie ZH, et al. – Researchers wanted to figure whether KIAA1522 overexpression promoted tumorigenicity and metastasis of esophageal cancer cells through potentiating the extracellular signal-regulated kinase (ERK) activity. Via potentiating the ERK activity, upregulation of KIAA1522 appeared to enhance tumorigenicity and metastasis of esophageal squamous cell carcinoma (ESCC) cells. In light of these findings, they suggested the oncogenic roles of aberrant expression of KIAA1522 in ESCC. Moreover, it seemed to serve as a novel molecular target in ESCC treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries